Dapagliflozin

Xi'an Huawave Biotech Co., Ltd. is a professional Dapagliflozin manufacturer and Dapagliflozin supplier . We are committed to providing customers with professional research and development, production and sales, as well as OEM and ODM processing services.
The primary efficacy of Dapagliflozin lies in its ability to manage blood glucose levels in patients with type 2 diabetes. Here are the key points outlining its effectiveness:

1. Blood Glucose Control:

   • Dapagliflozin acts as an adjunct to diet and exercise in improving glycemic control among adults with type 2 diabetes.
   • By inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidney, it reduces the reabsorption of glucose from the bloodstream into the body, leading to increased urinary glucose excretion and subsequently lower blood glucose levels.

2. Insulin Independence:

   • Its mechanism of action is independent of insulin secretion or action, making it a suitable option for patients with varying degrees of insulin resistance or secretion capacity.

3. Cardiovascular Benefits:

   • Studies have shown that Dapagliflozin may offer cardiovascular protection by reducing the risk of certain cardiovascular events, such as myocardial infarction and stroke, in patients with type 2 diabetes.

4. Weight Loss:

   • Due to the increased excretion of glucose and associated calories in the urine, Dapagliflozin may contribute to weight loss in some patients.

5. Blood Pressure Reduction:

   • Dapagliflozin has a mild diuretic effect, which may help to lower blood pressure in some patients.

It's important to note that Dapagliflozin should be used as prescribed by a healthcare provider and in conjunction with diet and exercise for optimal efficacy. Additionally, patients should be aware of potential adverse reactions and monitor their health closely while taking the medication.

Dapagliflozin  commonly known as Dagliejing in Chinese, is primarily used for the following purposes:

1. Blood Glucose Lowering: It serves as a novel oral antidiabetic drug. By inhibiting the sodium-glucose cotransporter 2 (SGLT2) expressed in the kidney, it reduces the reabsorption of filtered glucose, thereby increasing urinary glucose excretion and lowering blood glucose levels. This mechanism of action is independent of insulin.
2. Improving Beta Cell Function: When used in combination with other diabetic medications such as metformin and saxagliptin, it can enhance beta cell function index, facilitating insulin release and efficacy. This is particularly beneficial in addressing obesity associated with type 2 diabetes.
3. Mild Blood Pressure Reduction: Due to its osmotic diuretic effect, Dapagliflozin also exhibits mild antihypertensive properties.
4. Cardiovascular Protection: It can reduce the risk of non-fatal myocardial infarction, cardiovascular death, and non-fatal stroke in patients with type 2 diabetes.

It is primarily indicated for the treatment of type 2 diabetes in adults, as an adjunct to diet and exercise, or as monotherapy when metformin is not tolerated. However, it should not be used in patients with type 1 diabetes, diabetic ketoacidosis, severe renal insufficiency, end-stage renal disease, or those undergoing dialysis. Regular monitoring of renal function is required during treatment.

Please note that the use of Dapagliflozin may be associated with adverse reactions such as genitourinary infections, nasopharyngitis, constipation, dyslipidemia, limb pain, and ketoacidosis. Therefore, it is important to closely monitor patients' responses during treatment and discontinue the drug immediately if any adverse reactions occur.